CD8A and pancreatic ductal adenocarcinoma: found that tryptophan-derived microbial metabolites in pancreatic ductal adenocarcinoma (PDAC) activated the aryl hydrocarbon receptor (AhR) in tumor-associated macrophages (TAMs) and suppressed CD8 T cell-mediated anti-tumor immunity (74).